The Efficiency of the EORTC Scoring System for the Prediction of Recurrence and Progression of Non-muscle-invasive Bladder Cancer Treated by Bacillus Calmette-Guerin Immunotherapy

By Ajili Faouzia  

Ultrastructural Pathology, Vol. 37, Iss. 4, 2013-08 ,pp. : 249-253

Informa Healthcare

Access to resources Recommend Favorite

Tumor Multiplicity Is an Independent Prognostic Factor of Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin Immunotherapy

By Ajili Faouzia   Manai Mohamed   Darouiche Amine   Chebil Mohamed   Boubaker Samir  

Ultrastructural Pathology, Vol. 36, Iss. 5, 2012-10 ,pp. : 320-324

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Value of Tumor-associated Macrophages Count in Human Non-muscle-invasive Bladder Cancer Treated by BCG Immunotherapy

By Ajili Faouzia  

Ultrastructural Pathology, Vol. 37, Iss. 1, 2013-02 ,pp. : 56-61

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Value of Bcl-2 and Bax Tumor Cell Expression in Patients with Non Muscle-Invasive Bladder Cancer Receiving Bacillus Calmette-Guerin Immunotherapy

By Ajili Faouzia   Kaabi Belhassen   Darouiche Amine   Tounsi Haifa   Kourda Nadia   Chebil Mohamed   Manai Mohamed   Boubaker Samir  

Ultrastructural Pathology, Vol. 36, Iss. 1, 2012-08 ,pp. : 31-39

Informa Healthcare

Access to resources Recommend Favorite

Prediction of response to bacillus Calmette-Guérin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio

By                  

Experimental and Therapeutic Medicine, Vol. 4, Iss. 3, 2012-01 ,pp. : 459-464

Spandidos Publications

Access to resources Recommend Favorite